SCHEMBL22938459

SCHEMBL22938459

CC1(C)CCC(C)(C)c2cc3c(Br)coc3cc21

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
RARB P10826 4/20 0.46
RARG P13631 4/20 0.46
RARA P10276 3/20 0.46
RXRA P19793 5/20 0.38
RXRB P28702 2/20 0.32
RXRG P48443 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23446006 0.86 RARA (0.35) RARBRARGRARA
SCHEMBL23446022 0.83 RARA (0.34) RARBRARGRARA
SCHEMBL23446563 0.80 RARG (0.37) RARBRARGRARA
SCHEMBL6678059 0.71 RXRA (0.49) RARBRARGRARARXRARXRB
SCHEMBL22938032 0.70 RARA (0.38) RARBRARGRARARXRARXRB
SCHEMBL2194086 0.69 KDM4E (0.49) RARBRARGRARA
SCHEMBL25129965 0.66 RXRA (0.45) RARBRARGRARARXRARXRB
SCHEMBL11599145 0.66 RXRA (0.42) RARBRARGRARARXRARXRB
SCHEMBL21794119 0.66 RXRA (0.38) RARBRARGRARARXRARXRB
SCHEMBL23422175 0.66 RXRA (0.36) RARBRARGRARARXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12435098-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2025-10-07 US disclosed
US-11780856-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-10-10 US disclosed
US-11780856-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-10-10 US disclosed
WO-2023172111-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2023-09-14 WO disclosed
US-11685751-B2 Compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2023-06-27 US disclosed
US-11685751-B2 Compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2023-06-27 US disclosed
US-20220251118-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2022-08-11 US disclosed
EP-3919500-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-12-08 EP disclosed
EP-3907228-A1 COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG Chem, Ltd. (KR) 2021-11-10 EP disclosed
WO-2021107705-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2021-06-03 WO disclosed
WO-2021107694-A1 ORGANIC LIGHT-EMITTING ELEMENT 주식회사 엘지화학 2021-06-03 WO disclosed
WO-2021107681-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2021-06-03 WO disclosed
WO-2021020931-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2021-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220251118-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRKL, AHR, ATXN2L RARB 2226/4885RARG 2425/4885RARA 2346/4885
US-11780856-B2 Compound and organic light-emitting device comprising same CRY1, CRY2, LEF1 RARB 1767/4885RARG 1720/4885RARA 992/4885
US-12435098-B2 Heterocyclic compound and organic light-emitting device comprising same CRKL, AHR, ATXN2L RARB 2226/4885RARG 2425/4885RARA 2346/4885
US-11685751-B2 Compound and organic light-emitting element comprising same CRY1, CRY2, LEF1 RARB 874/4885RARG 738/4885RARA 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.